LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,360,000 | -8.8% | 8,921 | -40.5% | 0.01% | 0.0% |
| Q4 2020 | $1,492,000 | +5.7% | 15,004 | +1.4% | 0.01% | 0.0% |
| Q3 2020 | $1,411,000 | -4.5% | 14,804 | +12.1% | 0.01% | -16.7% |
| Q2 2020 | $1,477,000 | +30.1% | 13,204 | -15.4% | 0.01% | +20.0% |
| Q1 2020 | $1,135,000 | -20.0% | 15,604 | +14.7% | 0.01% | 0.0% |
| Q4 2019 | $1,419,000 | -8.0% | 13,604 | -12.3% | 0.01% | +11.1% |
| Q3 2019 | $1,543,000 | -16.1% | 15,504 | -3.7% | 0.01% | -30.8% |
| Q2 2019 | $1,838,000 | +120.9% | 16,104 | +143.2% | 0.01% | +116.7% |
| Q1 2019 | $832,000 | -10.2% | 6,621 | -2.9% | 0.01% | -25.0% |
| Q4 2018 | $926,000 | -52.6% | 6,821 | -4.1% | 0.01% | -46.7% |
| Q3 2018 | $1,952,000 | +30.6% | 7,113 | -1.4% | 0.02% | +50.0% |
| Q2 2018 | $1,495,000 | -2.8% | 7,213 | -22.5% | 0.01% | 0.0% |
| Q1 2018 | $1,538,000 | – | 9,313 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |